Copy Link Print Information

Otilimab

(Synonyms: GSK 3196165; MOR103)
Customer Review

Based on 1 Customer Validation

Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor.

For research use only. We do not sell to patients.

  • Purity: 99.29%
  • CAS No.: 1638332-55-4
  • Molecular Weight:142.22 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Otilimab
  • Experimental Validation Results for Otilimab
  • Otilimab Chemical Structure
    Otilimab Chemical Structure
CAS No.: 1638332-55-4
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Otilimab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 lambda2

  • 1/16

    Otilimab (HY-P99795) neutralizes Recombinant Human GM-CSF (HY-P7016A) induced proliferation in the TF-1 human erythroleukemic cell line. The Neutralization Dose (ND50) for this effect is 0.09348 μg/mL in the presence of 0.5 ng/mL Recombinant Human GM-CSF.

  • Otilimab Chemical Structure
    1/16
  • Otilimab
  • Otilimab (HY-P99795) neutralizes Recombinant Human GM-CSF (HY-P7016A) induced proliferation in the TF-1 human erythroleukemic cell line. The Neutralization Dose (ND50) for this effect is 0.09348 μg/mL in the presence of 0.5 ng/mL Recombinant Human GM-CSF.
  • Human IgG1 lambda2